1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) ForumMotherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
My story is similar to so many. We were blessed with a wonderful daughter 8 years ago, following a pregnancy cursed by hyperemesis.6 years later we decided to try again, though it took us 2 years to concieve!! The hyperemesis returned but this time far worse than I could ever have imagined.Depite hospital care, IV therapy and all the anti-emetics in the drug cupboard, the constant nausea and vommiting gained the upper hand and to my shame I terminated my pregnancy.It is 6 months now, and I desperately want another chance. It is clear that I need to be preemptive of the symptoms though your algorithym is based from Canada and certain medications are not available in the UK.Would it be appropriate to use ondansetron preemptively as it was the one medication that provided me with any form of relief during my last pregnancy?
Consult your physician. If you used the ondansetron before and it worked, it may be appropriate to use it again at the very first moment that you have any NVP.